Skip to main content
Clinical Trials/IRCT20210102049912N1
IRCT20210102049912N1
Recruiting
Phase 3

Comparing the effect of standard treatment with and without vitamin A supplementation in improving the clinical symptoms of outpatients with COVID-19

Arak University of Medical Sciences0 sites140 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Arak University of Medical Sciences
Enrollment
140
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Having clinical signs and test results that confirm COVID\-19
  • CRP level higher than 0\.3 mg per liter
  • Having an ESR higher than 22 mm per hour for women and 29 mm per hour for men

Exclusion Criteria

  • Having any autoimmune disease (lupus, MS, etc.)
  • Suffering from diseases that interfere with the absorption of vitamin A.
  • Consumers of vitamin A supplements
  • Patients with severe renal insufficiency and dialysis
  • Patients with underlying liver disease

Outcomes

Primary Outcomes

Not specified

Similar Trials